![Thomas Willemsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Willemsen is currently the President, Chief Executive Officer & Director at Tessa Therapeutics Ltd since 2022.
Previously, he worked as Senior Vice President-Asia Pacific Region at Takeda Pharmaceuticals U.S.A., Inc. Mr. Willemsen holds an MBA from the University of Trier and an undergraduate degree from Sun Yat-Sen University.
| Sociétés | Poste | Fin |
|---|---|---|
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Directeur Général | - |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Trier
 University of Trier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Engages in the development and commercialization of cancer immunotherapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
